AI Summary
This grant opportunity aims to expand the therapeutic pipeline for Alzheimer's Disease and Related Dementias by funding preclinical validation and drug discovery for novel candidate targets. The funding is provided through a U01 grant mechanism, but clinical trials are not allowed under this specific solicitation.